// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "HTML RECOMMEND INFRINGE proteomics data acquisition method SP MC PATO CLO organism PO TAB ... CV collision energy MAGE QY SH INFORMATION label HCD PP COLUMN PSI BUT THAT BMC PMID MUST FOR HF PRIDE:0000659 PURPOSE TO MAJOR CS source name FDR ID EBI JA OR STANDARDS instrument HANCESTRO IS LC SILAC SDRF PEPTIDESEQ XL WILL cleavage agent details technical replicate MIAME individual ISA CL XML spiked compound CF developmental stage MERCHANTABILITY MS:1001251 EFO alkylation reagent REQUIRES CELL dissociation method NOTE VK RECOMMENDED DTT characteristics biosample accession number HUPO REQUIRED DJ OPTIONAL age replicate RIGHTS LIMITED AS PMCID NOT ANY EM UBERON exclamation fractionation method MT SHALL COULD III fraction identifier mass CT BRENDA ZFA INITIATIVE AC FITNESS reduction reagent MONDO biological replicate cell type sample data file MS PARTICULAR CID disease PRM ENVO URI SRM HEREIN SWATH WARRANTIES depletion MHC ROW SHOULD IMPORTANT THE CPTAC EXPRESS ALL PS INCLUDING MAY IAA PTM RFC TIP EW BE TMT PROTEOMICS URL disease stage IDF IMPLIED NCBI DDA BTO CN pooled sample DISCLAIMS sex source name_ and _assay name USE TA NCE PRIDE II file your MOD MINOR DOID OF WARRANTY PATCH LI SN organism part NT RAW VCF README ancestry category DIA"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "HTML RECOMMEND INFRINGE proteomics data acquisition method SP MC PATO CLO organism PO TAB ... CV collision energy MAGE QY SH INFORMATION label HCD PP COLUMN PSI BUT THAT BMC PMID MUST FOR HF PRIDE:0000659 PURPOSE TO MAJOR CS FDR EBI JA OR STANDARDS instrument HANCESTRO IS LC SILAC SDRF PEPTIDESEQ XL WILL cleavage agent details technical replicate MIAME individual ISA CL spiked compound CF MERCHANTABILITY MS:1001251 EFO alkylation reagent REQUIRES CELL dissociation method VK RECOMMENDED DTT biosample accession number HUPO REQUIRED DJ OPTIONAL age RIGHTS LIMITED AS PMCID NOT ANY EM UBERON fractionation method MT SHALL COULD III fraction identifier mass CT BRENDA ZFA INITIATIVE AC FITNESS reduction reagent MONDO biological replicate cell type data file MS PARTICULAR CID disease PRM ENVO URI SRM HEREIN SWATH WARRANTIES depletion MHC ROW SHOULD THE CPTAC EXPRESS ALL PS INCLUDING MAY IAA PTM RFC EW BE TMT PROTEOMICS URL disease stage IDF IMPLIED NCBI DDA BTO CN pooled sample DISCLAIMS sex USE TA NCE PRIDE II MOD MINOR DOID OF WARRANTY PATCH LI SN organism part NT RAW VCF README ancestry category DIA"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO:0005138 CL:0000084 UBERON:0001977 CL:0000236 PATO UBERON:0000955 MONDO:0005301 PO organism CL:0000233 CL:0000788 MONDO:0005180 synthetic peptide UBERON:0002048 MONDO:0004989 PATO:0001340 xenograft CL:0000540 MONDO:0005575 CL:0000182 CL:0000057 MUST UBERON:0001969 source name CL:0000623 ID HANCESTRO CL:0000232 CL:0000451 CL:0000624 MONDO:0100096 CL:0000898 SDRF DSS disease model individual CL PATO:0000384 developmental stage CL:0000787 EFO UBERON:0001155 enrichment process NOTE UBERON:0002097 age lib CL:0000815 CL:0000235 compound UBERON:0000178 COVID PDX UBERON exclamation UBERON:0002113 PATO:0000461 CML CL:0000813 MONDO:0004975 NSG NK MONDO biological replicate UBERON:0002107 MONDO:0008383 disease MONDO:0005148 MONDO:0005105 UBERON:0000948 depletion SHOULD IMPORTANT UBERON:0001359 MONDO:0004946 ALL MAY PTM TIP URL CL:0000625 CL:0000576 NCBI CL:0000066 sex APP CL:0000913 PATO:0000383 CSF DOID UBERON:0000310 organism part UBERON:0001088 cell type ancestry category"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO:0005138 CL:0000084 UBERON:0001977 CL:0000236 PATO UBERON:0000955 MONDO:0005301 PO organism CL:0000233 CL:0000788 MONDO:0005180 synthetic peptide UBERON:0002048 MONDO:0004989 PATO:0001340 xenograft CL:0000540 MONDO:0005575 CL:0000182 CL:0000057 MUST UBERON:0001969 source name CL:0000623 ID HANCESTRO CL:0000232 CL:0000451 CL:0000624 MONDO:0100096 CL:0000898 SDRF DSS disease model individual CL PATO:0000384 developmental stage CL:0000787 EFO UBERON:0001155 enrichment process UBERON:0002097 age CL:0000815 CL:0000235 compound UBERON:0000178 COVID PDX UBERON UBERON:0002113 PATO:0000461 CML CL:0000813 MONDO:0004975 NSG NK MONDO biological replicate UBERON:0002107 MONDO:0008383 disease MONDO:0005148 MONDO:0005105 UBERON:0000948 depletion SHOULD UBERON:0001359 MONDO:0004946 ALL MAY PTM URL CL:0000625 CL:0000576 NCBI CL:0000066 sex APP CL:0000913 PATO:0000383 CSF DOID UBERON:0000310 organism part UBERON:0001088 cell type ancestry category"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C27971 menopausal status organism IV PD tumor grade diet gestational age NCIT:C71732 smoking status height NCIT:C53556 HIPAA UO NCIT:C28054 alcohol consumption ID NCIT:C27970 HANCESTRO treatment status MONDO:0004995 PREFERRED CHEBI:6801 NCIT:C14167 weight SDRF sampling time point body mass index individual time post treatment EFO prior treatment NOTE NCIT:C81327 pregnancy status treatment age MONDO:0011122 MONDO:0005300 breast cancer subtype NCIT:C4870 compound NCIT:C18058 NCI NCIT:C18213 NCIT:C81328 NCIT:C65108 secondary condition exclamation NCIT:C62723 III MONDO:0004979 ACE NCIT:C53553 NCIT:C28076 ethnicity NCIT:C28079 NCIT:C15445 MONDO HANCESTRO:0009 PR NCIT:C53554 disease CHEBI:41774 MONDO:0005148 pre-existing condition NCIT:C65107 NCIT:C16358 NCIT IMPORTANT TNM staging HANCESTRO:0005 TNM CHEBI:27899 NCIT:C14169 NCIT:C15632 NCIT:C68804 disease stage NCIT:C18206 NCIT:C28078 NCIT:C15313 NCIT:C27966 Ann Arbor stage CHEBI:28748 GDPR dose BMI sex MONDO:0005044 NCIT:C28077 NCIT:C14168 NCIT:C53555 NCIT:C14174 II AJCC MONDO:0002050 HANCESTRO:0006 HANCESTRO:0010 NCIT:C65106 NCIT:C15262 NCIT:C15329 ER organism part medication history Dukes stage treatment response ancestry category"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C27971 menopausal status organism IV PD tumor grade diet gestational age NCIT:C71732 smoking status height NCIT:C53556 HIPAA UO NCIT:C28054 alcohol consumption ID NCIT:C27970 HANCESTRO treatment status MONDO:0004995 PREFERRED CHEBI:6801 NCIT:C14167 weight SDRF sampling time point body mass index individual time post treatment EFO prior treatment NCIT:C81327 pregnancy status treatment age MONDO:0011122 MONDO:0005300 breast cancer subtype NCIT:C4870 compound NCIT:C18058 NCI NCIT:C18213 NCIT:C81328 NCIT:C65108 secondary condition NCIT:C62723 III MONDO:0004979 ACE NCIT:C53553 NCIT:C28076 ethnicity NCIT:C28079 NCIT:C15445 MONDO HANCESTRO:0009 PR NCIT:C53554 disease CHEBI:41774 MONDO:0005148 pre-existing condition NCIT:C65107 NCIT:C16358 NCIT TNM staging HANCESTRO:0005 TNM CHEBI:27899 NCIT:C14169 NCIT:C15632 NCIT:C68804 disease stage NCIT:C18206 NCIT:C28078 NCIT:C15313 NCIT:C27966 Ann Arbor stage CHEBI:28748 GDPR dose BMI sex MONDO:0005044 NCIT:C28077 NCIT:C14168 NCIT:C53555 NCIT:C14174 II AJCC MONDO:0002050 HANCESTRO:0006 HANCESTRO:0010 NCIT:C65106 NCIT:C15262 NCIT:C15329 ER organism part medication history Dukes stage treatment response ancestry category"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "LTQ MS:1001917 UNIMOD:4 exclamation SILAC UNIMOD:737 SDRF MT XL technical replicate proteomics data acquisition method cleavage agent details MSD file uri TIP MS:1001309 fraction identifier MS:1001303 TMT RPPA TS MGF ELISA CF scan window upper limit URL ST MS:1001251 precursor mass tolerance fragment mass tolerance label UNIMOD MM UNIMOD:1 AC PP DDA TOF proteomexchange accession number MRM NOTE PSI RECOMMENDED sample KR TA FTP MS MUST MS:1001313 data file PRIDE PRM REQUIRED HF MOD URI modification parameters fraction MS:1001306 SCIEX SRM CS scan window lower limit ID SHOULD MS2 analyzer type NT instrument RAW PRIDE:0000663 UNIMOD:35 IMPORTANT MS1 scan range DIA UNIMOD:21"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "LTQ MS:1001917 UNIMOD:4 SILAC UNIMOD:737 SDRF MT XL technical replicate proteomics data acquisition method cleavage agent details MSD file uri MS:1001309 fraction identifier MS:1001303 TMT RPPA TS MGF ELISA CF scan window upper limit URL ST MS:1001251 precursor mass tolerance fragment mass tolerance label UNIMOD MM UNIMOD:1 AC PP DDA TOF proteomexchange accession number MRM PSI RECOMMENDED KR TA FTP MS MUST MS:1001313 data file PRIDE PRM REQUIRED HF MOD URI modification parameters MS:1001306 SCIEX SRM CS scan window lower limit ID SHOULD MS2 analyzer type NT instrument RAW PRIDE:0000663 UNIMOD:35 MS1 scan range DIA UNIMOD:21"
  }
];
